baber/WOPTO huggingface dataset:
Patent AU-2006276732-B2 (AU)
Title: Method for wavelet denoising of controlled source electromagnetic survey data
Inventor: WILLEN DENNIS E
IPC: G01V1/00
Filed: 2006-07-11
Granted: 2011-04-28
Abstract: Method for denoising a receiver signal from a controlled source electromagnetic survey. A discrete wavelet transform is performed on the signal, and the resulting detail coefficients are truncated using a selected threshold value, which may be zero. Further levels of decomposition may be performed on the approximation coefficients from the preceding level. After the final level of decomposition, a denoised signal is restructured by performing the inverse wavelet transformation on the last set of approximation coefficients combined with the thresholded detail coefficients accumulated from all levels of decomposition.
Patent AU-2006300068-B2 (AU)
Title: Closure assembly for container
Inventor: BACK YOUNG JA
IPC: B65D41/28
Filed: 2006-10-12
Granted: 2010-08-26
Abstract: Disclosed is a closure assembly for a container including an external cap and an internal cap coupled to the external cap to securely seal the container and be convenient for use. The closure assembly includes a container stored with contents and having an outlet opening formed on an upper portion thereof, an internal cap tightly fitted into the outlet opening, an external cap engaged to an outside of the outlet opening, and a resilient coupling member integrally formed on an upper portion of the internal cap and fixed to a bottom of the external cap.
Patent AU-2006309551-B2 (AU)
Title: Use of combination of anti-angiogenic substance and c-kit kinase inhibitor
Inventor: YAMAMOTO YUJI
IPC: A61K31/4409
Filed: 2006-11-07
Granted: 2012-04-19
Abstract: Disclosed are: a pharmaceutical composition having an excellent anti-tumor effect; and a therapeutic method for cancer. 4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7 -methoxy-6-quinolinecarboxamide or an analogue thereof can be used in combination with a substance having a c-kit kinase-inhibiting activity to produce an excellent anti-tumor effect.
Patent AU-2006320066-B2 (AU)
Title: Metering apparatus
Inventor: HAYAKAWA TERUO
IPC: G01G19/387
Filed: 2006-11-17
Granted: 2012-04-26
Abstract: [PROBLEMS] To prevent lumps of articles (groups of articles stored in one lump from scattering and spreading when dropped, thus to prevent failures including one where a seal is caught in a filling device placed below and, at the same time, and to achieve higher article discharge speed obtained by a reduction in the length of a drop of the groups of articles, a reduction in contact resistance between the groups of articles and a sidewall during a drop, etc. [MEANS FOR SOLVING THE PROBLEMS] This metering apparatus is characterized in that the shapes and the opening degrees of gates (31, 32) can be changed so that the lower opening (3c) of a hopper (3) can be located within the reception opening (41) of the filling device (4) when viewed from above.
Patent AU-2006349571-B2 (AU)
Title: Foldable display system
Inventor: CHUNG KWO TZUO
IPC: G09F1/06
Filed: 2006-10-26
Granted: 2011-09-29
Abstract: Improvement in display for automatic assembly system wherein one automatic assembly part (1 1) formed by two walls (12) with wrinkles ( 13), agreeing by means of other wrinkles (14) to two walls (15) separated from each other by their free edges (16), form one hinging part in a system of tweezers. The part (1 1 ), by means of grooves (17) and (18) on its walls (12), receives an elastic band (19) inserted in hook-shaped grooves (8) and (10) of the juxtaposed rims (4), (5) and (6), (7) of both parts composing the body of the display (1). The part (1 1), by its walls (12) and walls (15), respectively accommodates between internal faces and the folds of the rims (4), (5) and (6), (7) of parts (2) and (3) composing the body of the display (1 ). Therefore, by means of working in form of tweezers combined to the elastic action, the part (1 1) may extend and become plain when the display ( 1) is closed and folded, while, after being vertically positioned and just a slight opening of its parts (2) and (3), they are automatically put apart from each other by hinging the walls (12) and (15) of the part (1 1), causing the display to be automatically assembled.
Patent AU-2007200890-B2 (AU)
Title: Supercritical Hydroextraction of Kerogen From Oil Shale Ores
Inventor: RENDALL JOHN S
IPC: C10G1/04
Filed: 2007-03-01
Granted: 2011-12-01
Abstract: Water is added to reduce the hydrogen consumption in kerogen conversion. The water is not 5 stripped from oil shale ores, instead up to 10% w/w of water is added in the kerogen conversion at 400-475.degree. C. The recycle solvent for conversion is changed to a high boiling point fraction of the oil, with a minimum boiling point of the order of 245.degree. C. Such repeated recycling of high boiling fraction oil with a hydrogen-donor mid-distillate will remove additional sulphur, oxygen and nitrogen. It improves the quality of the final product 10 oil. Most of the high boiling fraction of the oil will separate from the oil shale ores, at around 450.degree. C. and 650 psig. Then it is reduced to 250.degree. C. at 100 psig before distillation. Such column operates at around 10 to 250 psig, but preferably 50 psig. This improves thermal efficiency by avoiding the need to condense high boiling point vapors. The addition of water provides further enhancement in operating results. A consequence of 15 recycling high boiling oil fractions is the repeated hydrogenation and hydrocracking of that fraction to increase the proportions of lower boiling fractions. This reduces the asphaltene content of the recycled and final product streams. Such is similar to hydro-visbreaking of bitumen, in which both the asphaltene fraction and the sulphur content can be halved, resulting in a product of 25-30.degree. API gravity in a single pass. The recycling of high 20 boiling fraction means approximately half of the product oil is repeatedly recycled. There is no recycle of the low boiling fractions. It is expected that the intractable asphaltene content of about 5% of the product oil will be in suspension under hydro-treating and hydro-cracking conditions. These are removed with the solids after a supercritical solvent wash.
Patent AU-2007200928-B2 (AU)
Title: Manifold for gas enhanced surgical instruments
Inventor: PODHAJSKY RONALD J
IPC: A61B18/14
Filed: 2007-03-02
Granted: 2013-02-14
Abstract: MANIFOLD FOR GAS ENHANCED SURGICAL INSTRUMENTS Abstract There is disclosed a fluid supply manifold for use with various surgical instruments, such as, electrosurgical instruments (10). The fluid supply manifold (50) 5 includes two or more connection ports (54, 56, 58, 60) for receipt of sources of fluid supply by either bulk sources or sources contained within canisters. The manifold (50) may include a mixing chamber (64) for mixing the various sources of fluids within the manifold (50) or may include flow tubes (62) for providing the sources of fluid directly to the surgical instrument (12) to be mixed within the surgical instrument (12). Control 1o valves (74, 76, 78, 80) are associated with each of the connection ports (54, 56, 58, 60) to control the flow of fluids through the manifold (50). The manifold (50) may also include a gas inlet to facilitate drawing the fluids out of the various sources as well as mixing the fluids within the manifold (50). (10 c 'Ia I,4 . . . . . . - - - - - - - - - - - - - - - - - -- -- - - -
Patent AU-2007207648-B2 (AU)
Title: Cooling system and method
Inventor: LINGREY DAVID J
IPC: H05K7/20
Filed: 2007-01-16
Granted: 2012-06-14
Abstract: A system for cooling a data center designed to house a plurality of electronic equipment racks, with each equipment rack being adapted to support at least one piece of electronic equipment and having an industry-standard width, includes at least one cooling rack including a housing having a width approximately one-half the width of each of the plurality of equipment racks. The system further includes other components associated with the cooling system. Methods of cooling a data center are further disclosed.
Patent AU-2007212623-B2 (AU)
Title: Delivery system and method for self-centering a proximal end of a stent graft
Inventor: CHRISTIAN FLETCHER
IPC: A61F2/06
Filed: 2007-02-02
Granted: 2012-07-12
Abstract: A method for implanting a prosthesis centrally within a curved lumen includes loading a prosthesis into a delivery sheath, advancing the sheath in a patient towards the curved lumen to place at least the proximal end of the prosthesis within the curved lumen, and centering the proximal end of the prosthesis and/or the distal end of the sheath within the curved lumen. In a first advancing step, the outer catheter containing the inner sheath is advanced together towards the curved lumen to a location proximal of the curved lumen and, in a second advancing step, the inner sheath containing the prosthesis is advanced into the curved lumen to place at least the proximal end within the curved lumen while the outer catheter substantially remains at the location. After centering, the proximal end of the prosthesis is deployed centered within the curved lumen.
Patent AU-2007266836-B2 (AU)
Title: Pyridinone and pyridazinone derivatives as inhibitors of poly(ADP-ribose)polymerase (PARP)
Inventor: LLAUGER BUFI LAURA
IPC: C07D237/14
Filed: 2007-05-25
Granted: 2013-09-26
Abstract: The present invention relates to compounds of formula (I): and pharmaceutically acceptable salts or tautomers thereof which are inhibitors of poly(ADP-ribose)polymerase (PARP) and thus useful for the treatment of cancer, inflammatory diseases, reperfusion injuries, ischaemic conditions, stroke, renal failure, cardiovascular diseases, vascular diseases other than cardiovascular diseases, diabetes mellitus, neurodegenerative diseases, retroviral infections, retinal damage, skin senescence and UV-induced skin damage, and as chemo- or radiosensitizers for cancer treatment.
Patent AU-2007278747-B2 (AU)
Title: An apparatus for pressure sensing
Inventor: ARKWRIGHT JOHN WILLIAM
IPC: A61B5/00
Filed: 2007-07-23
Granted: 2013-03-21
Abstract: The present invention provides an apparatus for pressure sensing. The apparatus comprises a series of Bragg gratings and a light guide incorporating the series of Bragg gratings. The apparatus also comprises a plurality of moveable wall portions having opposite first and second sides. Each moveable wall portion is positioned so that a change in pressure at one of the sides relative to a pressure at the other side will move the moveable wall portion that is coupled to respective Bragg gratings so that the movement of one of the moveable wall portion causes a force on the respective Bragg grating resulting in a change in strain of the respective Bragg grating. An internal space at each Bragg grating is in fluidal communication with an internal space at an adjacent Bragg grating whereby pressure differences between adjacent internal spaces are reduced.
Patent AU-2007314342-B2 (AU)
Title: Anilinopiperazine Derivatives and methods of use thereof
Inventor: SIDDIQUI M ARSHAD
IPC: C07D417/12
Filed: 2007-10-29
Granted: 2013-02-21
Abstract: The present invention relates to novel Anilinopiperazine Derivatives of Formula (I), compositions comprising the Anilinopiperazine Derivatives, and methods for using the Anilinopiperazine Derivatives for treating or preventing a proliferative disorder, cancer, an anti-proliferative disorder, inflammation, arthritis, a central nervous system disorder, a cardiovascular disease, alopecia, a neuronal disease, an ischemic injury, a viral disease, a fungal infection, or a disorder related to the activity of a protein kinase.
Patent AU-2008200842-B2 (AU)
Title: Tricyclic thrombin receptor antagonists
Inventor: WENXUE WU
IPC: C07D405/06
Filed: 2008-02-22
Granted: 2011-09-15
Abstract: Heterocyclic-substituted tricyclics of the formula (I) or a pharmaceutically acceptable salt thereof, wherein: 5 the dotted line represents an optional single bond; ----- represents an optional double bond; n is 0-2; Q is cycloalkyl, optionally substituted by R'3 and R14 ; each R" is independently selected from H, (C,-C6 )alkyl, (03 -C5 )cycloalkyl, 10 -(CH 2)neNHC(O)OR'*O, -(CH 2)neNHC(O)R'", -(CH 2),,6NHC(O)NR 4 R5, -(CH 2)neNHSO 2 R0 , -(CH 2)n6 NH S0 2N R4R, and -(CH 2)nsC(O)NR 28 R29 where ne is 0-4, haloalkyl, and halogen; each R14 is independently selected from H, (C,-C)alkyl, -OH, (C-C)alkoxy, R27-aryl(C1-C5)alkyl, heteroaryl, heteroarylalkyl, heterocycyl, is heterocycylalkyl, -(CH 2)n6NHC(O)OR'b, -(CH2)neNHC(O)R'Ib, -(CH 2)neNHC(O)NR 4R5, -(CH 2)meNHSO 2 R, -(CH 2)n6NHSO 2NR4R5 , and -(CH 2)neC(O)NRaR" where n, is 0-4, halogen and haloalkyl; or R's and R14 taken together form a spirocyclic or a heterospirocyclic ring of 3-6 atoms; 20 wherein at least one of R'5 or R" is selected from the group consisting of -(CH 2)neNHC(O)OR"", -(CH 2)neNHC(O) R'O, -(CH 2)neNHC(O)NR 4R', -(CH2)sNHSO 2 R'6 , -(CH 2),nNHSO 2NRR 6, and -(CH 2)neC(O)NR 2 R29 where na is 04; Het is a mono- or bi-cyclic optionally substituted heteroaryl group; and 25 B is a bond, alkylene, or optionally substituted alkenylene or alkynylene, wherein the remaining substituents are as defined in the specification, are disclosed, as well as pharmaceutical compositions containing them and a method of treating diseases associated with thrombosis, atherosclerosis, restenosis, hypertension, angina pectoris, arrhythmia, heart failure, and cancer by administering said compounds. 30 Combination therapy with other cardiovascular agents is also claimed. y- R .3 10 (CH 2)n, R x R R Q (I) Het
Patent AU-2008202276-B2 (AU)
Title: Pharmaceutical compositions comprising peranhydrocyclodextrin
Inventor: LUDWIG KIS GEORG
IPC: A61K47/40
Filed: 2008-05-22
Granted: 2011-08-25
Abstract: 5 The present invention relates to a pharmaceutical composition comprising a peranhydrocyclodextrin a drug and a carrier, to the use of a peranhydrocyclodextrin as a drug transport enhancer (e.g. permeation enhancer), and to the use of a peranhydrocyclodextrin in the preparation of a pharmaceutical composition as a synergistic adjunctive system.
Patent AU-2008202521-B2 (AU)
Title: Enteric-coated glucosinolates and beta-thioglucosidases
Inventor: WEST LESLIE GEORGE
IPC: A23L29/00
Filed: 2008-06-06
Granted: 2013-08-15
Abstract: Abstract The present invention relates to a particulate composition comprising enteric coated glucosinolate and beta-thioglucosidase particles. The present invention further provides a method of converting glucosinolate to isothiocyanate in the small intestine comprising orally administering to a subject an enteric-coated chemoprotectant precursor composition comprising enteric-coated glucosinolate and beta thioglucosidase particles. In another aspect, uncoated glucosinolate and beta thioglucosidase particles may be provided in an enteric-coated capsule. Preferably, the glucosinolate is glucoraphanin and the beta-thioglucosidase is myrosinase. The enteric coating targets the compound for release in the small intestine where beta thioglucosidase enzyme converts glucosinolate to chemoprotectant isothiocyanate.
Patent AU-2008226645-B2 (AU)
Title: Salts of 3- (1H-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl] -pyrrole-2, 5-di one
Inventor: YOWELL GUY
IPC: C07D403/14
Filed: 2008-03-06
Granted: 2012-09-20
Abstract: The invention provides acid addition salts of 3-(1.H.-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione, crystalline forms thereof, processes for the preparation thereof, pharmaceutical compositions comprising them and uses thereof in therapeutic treatment.
Patent AU-2008229765-B2 (AU)
Title: Zonal diffractive multifocal intraocular lenses
Inventor: SIMPSON MICHAEL J
IPC: A61F2/16
Filed: 2008-10-02
Granted: 2014-06-05
Abstract: Docket 3354 US ZONAL DIFFRACTIVE MULTIFOCAL INTRAOCULAR LENSES The present invention generally provides multifocal ophthalmic lenses, e.g., multifocal intraocular lenses, that employ a central refractive region for providing a refractive focusing power and a diffractive region for providing two diffractive focusing powers. In many cases, the refractive focusing power provided by the lens's central 10 region corresponds to a far-focusing power that is substantially equal to one of the diffractive focusing powers while the other diffractive power corresponds to a near focusing power. As such, in m:ny cases, the focusing properties of the lenses are dominated by the far-focus ability, especially for small pupil sizes. it0,
Patent AU-2008259437-B2 (AU)
Title: Male contact for optical fibre
Inventor: HAMBLIN CHRISTOPHER
IPC: G02B6/38
Filed: 2008-05-07
Granted: 2012-10-11
Abstract: The invention relates to a male contact for an optical fibre (1), that comprises an outer body (2) of an elastically deformable material, a cylindrical guide (6) having a front portion (5) attached in the rear portion (4) of the outer body (2) and a rear portion (7) protruding from the rear portion (4) of the outer body (2). A cable adapter (65) extends through the cylindrical guide (6). An elongated floating ferrule (18) extends through the front portion (3) of the outer body (2). The ferrule (18) is connected to a ferrule holder (13) movably mounted in said outer body (2). It comprises abutment means (19) bearing on the first shoulders (11) of the outer body (2), and a helical spring (21) provided between the front portion (5) of the cylindrical guide (6) and the abutment means (19) of the ferrule holder (13). The cable adapter (65) is mounted so as to float within the cylindrical guide (6).
Patent AU-2008273426-B2 (AU)
Title: Di(arylamino)aryl compounds
Inventor: MATSUYA TAKAHIRO
IPC: C07D401/14
Filed: 2008-07-04
Granted: 2012-11-08
Abstract: [PROBLEMS] To provide a compound which is useful as an inhibitor of the kinase activity of an EML4-ALK fusion protein and an EGFR variant protein. [MEANS FOR SOLVING PROBLEMS] As the results of intensive studies on a compound having an effect of inhibiting the kinase activity of an EML4-ALK fusion protein and a EGFR variant protein, it has been found out that a di(arylamino)aryl compound has an activity of inhibiting the kinase activity of an EML4-ALK fusion protein and a EGFR variant protein. The above-described compound can be used as a medicinal composition for preventing and/or treating cancer, pulmonary cancer, non-small-cell pulmonary cancer, small-cell pulmonary cancer, EML4-ALK fusion polynucleotide positive and/or EGFR variant polynucleotide positive cancer, EML4-ALK fusion polynucleotide positive and/or EGFR variant polynucleotide positive pulmonary cancer, EML4-ALK fusion polynucleotide positive and/or EGFR variant polynucleotide positive non-small-cell pulmonary cancer, or the like.
Patent AU-2008285283-B2 (AU)
Title: Improvements relating to skin dressings
Inventor: WATSON LYNNE PATRICIA
IPC: A61L15/18
Filed: 2008-07-14
Granted: 2014-01-23
Abstract: A skin dressing is provided comprising a first component comprising a source of protons, a second component comprising a nitrite salt, the dressing comprising a non- thiol reductant, such that, when the first and second components are brought together and applied to a skin site the nitrite reacts to generate nitric oxide, increasing the pH of the dressing in contact with the skin from an acidic value to a more neutral value.
Patent AU-2008289199-B2 (AU)
Title: System and method for enforcing network device provisioning policy
Inventor: MORGAN JANE
IPC: G06F21/62
Filed: 2008-08-14
Granted: 2014-02-13
Abstract: Systems and methods are provided for enforcing a network device provisioning policy. In one embodiment, a method may employ a computer based system to restrict access to data center resources, receive provisioning requests for access to the data center resources, authorize the provisioning requests after compliance with the network provisioning policy and allow the network device to access authorized data center resources. In another embodiment, a system includes interfaces for provisioning policy, request and task status information. The information provided by these interfaces is then used to determine compliance with applicable network device provisioning policies and restrict or allow access to the data center resources according to the provisioning policy.
Patent AU-2008308950-B2 (AU)
Title: Anti-bacterial pyrocatechols and related methods
Inventor: JAMES BOYD THOMAS
IPC: A61Q11/00
Filed: 2008-09-29
Granted: 2011-12-22
Abstract: The invention includes a compound or an oral care composition comprising a compound represented by the structure (I): OH R R2 R (I) wherein R3 is selected from a hydrogen atom and a structure represented by: H m (H) wherein m is an integer of 0 to 100, R is independently selected from a first hydrocarbon structure having from 1 to 50 carbon atom and Rl and R2 are independently chosen from a hydrogen atom and a second hydrocarbon structure having 1 to 10 carbon atoms. Related methods are also disclosed.
Patent AU-2008349523-B2 (AU)
Title: Implant device for use in an implant system
Inventor: LUSCHER PATRICK
IPC: A61L27/56
Filed: 2008-01-29
Granted: 2013-10-24
Abstract: An implant device (10, 1 0a) including a hollow or planar body (14 or 14a) defining a mesh covering. A bioactive agent(s) is incorporated into or onto the body (14). The body (14) can include a woven, knitted, and/or non-woven fabric (30, 36, 37) and/or a polymeric film (38), each having a plurality of desirably sized openings (18). The implant device (10, 10a) is used in combination with a bone implant (16) to define an implant system (12). In one embodiment, the bone implant (16) includes an outer surface (44) that is generally covered by the implant device (10, 10a) so that the hollow or planar body (14, 14a) covers and conforms to at least a portion of the outer surface (44) of the bone implant (16). After implantation of the implant system (12), a desirable area of the outer surface (44) of the bone implant (16) is in direct contact with bone tissue. This secures primary stability and subsequent bone on- and in-growth for secondary stability.
Patent AU-2009200981-B2 (AU)
Title: Low-melting biocidal formulation
Inventor: FELDER PATRICK THOMAS
IPC: A01N25/22
Filed: 2009-03-10
Granted: 2014-02-27
Abstract: A low-melting biocidal composition comprising 4,5-dichloro-2-octyl-3(2H) isothiazolone, 3-iodopropargyl-N-butyl carbamate and at least one C1 C4 alkyl 4 hydroxybenzoate. The composition is stable with regard to agglomeration and crystallization at room temperature.
Patent AU-2009204475-B2 (AU)
Title: Method of making a crosslinked fiber membrane from a high molecular weight, monoesterified polyimide polymer
Inventor: OMOLE IMONA C
IPC: B01D59/12
Filed: 2009-01-06
Granted: 2012-11-29
Abstract: The present disclosure relates to a high molecular weight, monoesterified polyimide polymer. Such high molecular weight, monoesterified polyimide polymers are useful in forming crosslinked polymer membranes for the separation of fluid mixtures. According to its broadest aspect, the method of making a crosslinked membrane comprises the following steps: (a) preparing a polyimide polymer comprising carboxylic acid functional groups from a reaction solution comprising monomers and at least one solvent; (b) treating the polyimide polymer with a diol at esterification conditions in the presence of dehydrating conditions to form a monoesterified polyimide polymer; and (c) subjecting the monoesterified fiber to transesterification conditions to form a crosslinked fiber membrane, wherein the dehydrating conditions at least partially remove water produced during step (b). The crosslinked membranes can be used to separate at least one component from a feed stream including more than one component.